Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1996 1
2003 1
2005 1
2008 1
2009 2
2014 1
2017 1
2021 1
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Vaccine-associated thrombocytopenia.
Gan G, Liu H, Liang Z, Zhang G, Liu X, Ma L. Gan G, et al. Thromb Res. 2022 Dec;220:12-20. doi: 10.1016/j.thromres.2022.09.017. Epub 2022 Sep 26. Thromb Res. 2022. PMID: 36265409 Review.
In addition to common vaccine-related adverse reactions, some rare but serious adverse reactions have been reported, including secondary immune thrombocytopenia (ITP). The measles-mumps-rubella (MMR) vaccine is currently the only vaccine for which a cause-effect relationsh …
In addition to common vaccine-related adverse reactions, some rare but serious adverse reactions have been reported, including secondary imm …
Effect of early measles vaccination on long-term protection: A systematic review.
Xu J, Doyon-Plourde P, Tunis M, Quach C. Xu J, et al. Vaccine. 2021 May 21;39(22):2929-2937. doi: 10.1016/j.vaccine.2021.04.012. Epub 2021 Apr 27. Vaccine. 2021. PMID: 33926750 Free article. Review.
BACKGROUND: In North America, the first dose of a measles-containing vaccine (MCV1) is administered at 12 months of age. ...METHODS: This systematic review and meta-analysis evaluates the impact of MCV1 given at <12 months vs. 12 months of age on long-term immunogenicit …
BACKGROUND: In North America, the first dose of a measles-containing vaccine (MCV1) is administered at 12 months of age. ...METHODS: …
Pain caused by measles, mumps, and rubella vaccines: A systematic literature review.
Willame C, Henry O, Lin L, Vetter V, Baril L, Praet N. Willame C, et al. Vaccine. 2017 Oct 9;35(42):5551-5558. doi: 10.1016/j.vaccine.2017.08.068. Vaccine. 2017. PMID: 28893478 Free article. Review.
PURPOSE: The risk of post-vaccination adverse events (AEs) is a primary public health concern. ...This review describes and assesses the intensity of pain experienced by children post-vaccination with widely used Measles-Mumps-Rubella (MMR) vacc …
PURPOSE: The risk of post-vaccination adverse events (AEs) is a primary public health concern. ...This review describes and as …
Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context.
Casabona G, Berton O, Singh T, Knuf M, Bonanni P. Casabona G, et al. Expert Rev Vaccines. 2023 Jan-Dec;22(1):764-776. doi: 10.1080/14760584.2023.2252065. Expert Rev Vaccines. 2023. PMID: 37642012 Free article. Review.
AREAS COVERED: This narrative review contextualizes FC occurrence after the first MMRV vaccine dose from a clinical perspective and outlines approaches to attenuate FC occurrence post-vaccination. EXPERT OPINION: While the relative FC risk increases after the first …
AREAS COVERED: This narrative review contextualizes FC occurrence after the first MMRV vaccine dose from a clinical perspective and outlines …
Sex and age as determinants of the seroprevalence of anti-measles IgG among European healthcare workers: A systematic review and meta-analysis.
Bianchi FP, Stefanizzi P, Trerotoli P, Tafuri S. Bianchi FP, et al. Vaccine. 2022 May 20;40(23):3127-3141. doi: 10.1016/j.vaccine.2022.04.016. Epub 2022 Apr 28. Vaccine. 2022. PMID: 35491343 Free article. Review.
INTRODUCTION: The international literature shows good evidence of a significant rate of measles susceptibility among healthcare workers (HCWs). As such, they are an important public health issue. ...DISCUSSION: According to our meta-analysis, the prevalence of serosuscepti …
INTRODUCTION: The international literature shows good evidence of a significant rate of measles susceptibility among healthcare worke …
The spectrum of post-vaccination inflammatory CNS demyelinating syndromes.
Karussis D, Petrou P. Karussis D, et al. Autoimmun Rev. 2014 Mar;13(3):215-24. doi: 10.1016/j.autrev.2013.10.003. Autoimmun Rev. 2014. PMID: 24514081 Review.
The vast majority of post-vaccination CNS demyelinating syndromes, are related to influenza vaccination and this could be attributed to the high percentage of the population that received the vaccine during the HI1N1 epidemia from 2009 to 2012. Usually the symptoms …
The vast majority of post-vaccination CNS demyelinating syndromes, are related to influenza vaccination and this could be attr …
A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile.
Czajka H, Schuster V, Zepp F, Esposito S, Douha M, Willems P. Czajka H, et al. Vaccine. 2009 Nov 5;27(47):6504-11. doi: 10.1016/j.vaccine.2009.07.076. Epub 2009 Aug 7. Vaccine. 2009. PMID: 19665608 Review.
Priorix-Tetra (GlaxoSmithKline Biologicals) is a combined measles, mumps, rubella and varicella (MMRV) vaccine. Eight studies involving more than 3000 children were reviewed. Compared with co-administration of MMR (Priorix) and varicella (Varilrix) vaccines, the MMRV vacci …
Priorix-Tetra (GlaxoSmithKline Biologicals) is a combined measles, mumps, rubella and varicella (MMRV) vaccine. Eight studies involvi …
Clinical trials show similar safety outcomes including febrile convulsion rates for GSK's and Merck's measles-mumps-rubella (MMR) vaccines.
Habib MA, Povey M, Casabona G, Singh T, Abu-Elyazeed R. Habib MA, et al. Hum Vaccin Immunother. 2023 Dec 31;19(1):2188852. doi: 10.1080/21645515.2023.2188852. Hum Vaccin Immunother. 2023. PMID: 36988468 Free PMC article. Review.
Combined measles-mumps-rubella (MMR) vaccines produced by GSK (GSK-MMR) and Merck (Merck-MMR) have demonstrated effectiveness and an acceptable safety profile, as documented over decades of post-licensure use in various regions worldwide. ...Overall frequencies of febrile …
Combined measles-mumps-rubella (MMR) vaccines produced by GSK (GSK-MMR) and Merck (Merck-MMR) have demonstrated effectiveness and an …
Transverse myelitis and vaccines: a multi-analysis.
Agmon-Levin N, Kivity S, Szyper-Kravitz M, Shoenfeld Y. Agmon-Levin N, et al. Lupus. 2009 Nov;18(13):1198-204. doi: 10.1177/0961203309345730. Lupus. 2009. PMID: 19880568 Review.
A systematic review of PubMed, EMBASE and DynaMed for all English-language journals published between 1970 and 2009 was preformed, utilizing the key words transverse myelitis, myelitis, vaccines, post-vaccination, vaccination and autoimmunity. We have disclosed 37 r …
A systematic review of PubMed, EMBASE and DynaMed for all English-language journals published between 1970 and 2009 was preformed, utilizing …
Post-vaccination encephalomyelitis: literature review and illustrative case.
Huynh W, Cordato DJ, Kehdi E, Masters LT, Dedousis C. Huynh W, et al. J Clin Neurosci. 2008 Dec;15(12):1315-22. doi: 10.1016/j.jocn.2008.05.002. Epub 2008 Oct 30. J Clin Neurosci. 2008. PMID: 18976924 Free PMC article. Review.
Post-infectious and post-immunisation encephalomyelitis make up about three-quarters of cases, where the timing of a febrile event is associated with the onset of neurological disease. Post-vaccination ADEM has been associated with several vaccines such as rabies, d …
Post-infectious and post-immunisation encephalomyelitis make up about three-quarters of cases, where the timing of a febrile event is associ …
16 results